These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23298476)

  • 1. Impact of neuropeptide substance P an inflammatory compound on arachidonic acid compound generation.
    Nicoletti M; Neri G; Maccauro G; Tripodi D; Varvara G; Saggini A; Potalivo G; Castellani ML; Fulcheri M; Rosati M; Toniato E; Caraffa A; Antinolfi P; Cerulli G; Pandolfi F; Galzio R; Conti P; Theoharides TC
    Int J Immunopathol Pharmacol; 2012; 25(4):849-57. PubMed ID: 23298476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurogenic inflammation in acute pancreatitis.
    Hegde A; Bhatia M
    JOP; 2005 Sep; 6(5):417-21. PubMed ID: 16186661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of angiogenesis by endogenous substance P release and neurokinin-1 receptors during neurogenic inflammation.
    Seegers HC; Hood VC; Kidd BL; Cruwys SC; Walsh DA
    J Pharmacol Exp Ther; 2003 Jul; 306(1):8-12. PubMed ID: 12660314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of substance P and neurogenic inflammation in arsenic-induced early vascular dysfunction.
    Chen SC; Tsai MH; Wang HJ; Yu HS; Chang LW
    Toxicol Sci; 2007 Jan; 95(1):82-8. PubMed ID: 17056641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance P and immunoregulation.
    McGillis JP; Organist ML; Payan DG
    Fed Proc; 1987 Jan; 46(1):196-9. PubMed ID: 2433163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGF, substance P and stress, new aspects: a revisited study.
    Castellani ML; Galzio RJ; Felaco P; Tripodi D; Toniato E; De Lutiis MA; Conti F; Fulcheri M; Conti C; Theoharides TC; Caraffa A; Antinolfi P; Felaco M; Tete S; Pandolfi F; Shaik-Dasthagirisaheb YB
    J Biol Regul Homeost Agents; 2010; 24(3):229-37. PubMed ID: 20846471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance P and its Inhibition in Ocular Inflammation.
    Bignami F; Rama P; Ferrari G
    Curr Drug Targets; 2016; 17(11):1265-74. PubMed ID: 26477461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogen sulfide and substance P in inflammation.
    Bhatia M
    Antioxid Redox Signal; 2010 May; 12(10):1191-202. PubMed ID: 19803739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of substance P in the cardiovascular system.
    Mistrova E; Kruzliak P; Chottova Dvorakova M
    Neuropeptides; 2016 Aug; 58():41-51. PubMed ID: 26706184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurogenic inflammation. A model for studying efferent actions of sensory nerves.
    McDonald DM; Bowden JJ; Baluk P; Bunnett NW
    Adv Exp Med Biol; 1996; 410():453-62. PubMed ID: 9030340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of substance P on neurogenic inflammation in the rat dental pulp and inferior lip].
    Yamada Y
    Fukuoka Shika Daigaku Gakkai Zasshi; 1990; 17(2):198-214. PubMed ID: 1725514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptides and inflammation: the role of substance P.
    Payan DG
    Annu Rev Med; 1989; 40():341-52. PubMed ID: 2471450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance P in traumatic brain injury.
    Donkin JJ; Turner RJ; Hassan I; Vink R
    Prog Brain Res; 2007; 161():97-109. PubMed ID: 17618972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary afferent tachykinins are required to experience moderate to intense pain.
    Cao YQ; Mantyh PW; Carlson EJ; Gillespie AM; Epstein CJ; Basbaum AI
    Nature; 1998 Mar; 392(6674):390-4. PubMed ID: 9537322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of the substance P/neurokinin-1 receptor system in oral pain and inflammation.
    Velasco-Ortega E; Monsalve-Guil L; Jiménez-Guerra A; Ortiz-García I; Crespo De La Rosa JC; Coveñas R; Muñoz M
    J Biol Regul Homeost Agents; 2020; 34(1):215-219. PubMed ID: 32397696
    [No Abstract]   [Full Text] [Related]  

  • 16. Contribution of neuroimmune mechanisms to airway inflammation and remodeling during and after respiratory syncytial virus infection.
    Piedimonte G
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S66-74; discussion S74-5. PubMed ID: 12671455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance P: the relationship between receptor distribution in rat lung and the capacity of substance P to stimulate vascular permeability.
    Sertl K; Wiedermann CJ; Kowalski ML; Hurtado S; Plutchok J; Linnoila I; Pert CB; Kaliner MA
    Am Rev Respir Dis; 1988 Jul; 138(1):151-9. PubMed ID: 2462377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance P plays an important role in cell adhesion molecule 1-mediated nerve-pancreatic islet α cell interaction.
    Nakamura M; Inoh Y; Nakanishi M; Furuno T
    Biochem Biophys Res Commun; 2013 Aug; 438(3):563-7. PubMed ID: 23899526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neurobiology of vascular head pain.
    Moskowitz MA
    Ann Neurol; 1984 Aug; 16(2):157-68. PubMed ID: 6206779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of capsaicin on mast cell inflammation.
    Frydas S; Varvara G; Murmura G; Saggini A; Caraffa A; Antinolfi P; Tete' S; Tripodi D; Conti F; Cianchetti E; Toniato E; Rosati M; Speranza L; Pantalone A; Saggini R; Di Tommaso LM; Theoharides TC; Conti P; Pandolfi F
    Int J Immunopathol Pharmacol; 2013; 26(3):597-600. PubMed ID: 24067456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.